International momentum is evidenced by the 2026 symposium attracting participants from 73 countries, and highlighting OGM ...

In this week’s Tech Tuesday, our partners at UF Innovate and SCAD Media highlight Synvitta Diagnostics, a biotech company ...

Looking back on life sciences tools & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

Genomic assays have become indispensable tools in the management of early-stage invasive breast cancer, helping oncologists move beyond traditional pathologic staging to make more ...

Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the upcoming clinical availability of xH, a next-generation sequencing ...

There was a time when pregnancy tests did not merely announce impending parenthood. They opened the door to nine months of ...

Recombinant Lectin Production: To address the limitations of native extraction, CD BioGlyco offers recombinant production solutions based on bacterial, yeast, insect, and mammalian cell systems, ...

U.S. Market Expected to Hit USD 1.80 Billion by 2035; Europe Projected to Reach USD 1.67 Billion as Rare Disease Screening Programs Expand.Austin, United States, June 08, 2026 (GLOBE NEWSWIRE) -- “As ...

Molecular biomarkers can serve as useful diagnostic markers, as prognostic markers for predicting clinical behavior, or as targets for new therapeutic strategies. Application of expression microarray ...

For the cell biologist, identifying changes in gene expression using DNA microarrays is just the start of a long journey from tissue to cell. We discuss how chip users can first filter noise ...